{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T04:02:44Z","timestamp":1780718564808,"version":"3.54.1"},"reference-count":57,"publisher":"The Japanese Society for Medical Mycology","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Mycology Journal"],"published-print":{"date-parts":[[2026,4,30]]},"DOI":"10.3314\/mmj.26.011","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T22:12:38Z","timestamp":1780179158000},"page":"137-142","source":"Crossref","is-referenced-by-count":0,"title":["Clinical Diagnosis and Management of Ocular Fungal Infections"],"prefix":"10.3314","volume":"67","author":[{"given":"Kiyofumi","family":"Mochizuki","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Gifu University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Inuzuka","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Gifu University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taishi","family":"Miyase","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Gifu University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikumi","family":"Shiraki","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Gifu University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Kawakami","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Gifu Municipal Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1842","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Kohno S, Tamura K, Niki Y, Izumikawa K, Oka S, Ogawa K, et al: Executive summary of Japanese domestic guidelines for management of deep-seated mycosis 2014. Med Mycol J 57: E117–63, 2016.","DOI":"10.3314\/mmj.16-00010"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Pappas PG, Kauffman CA, Andes D, Benjamin DK Jr, Calandra TF, Edwards JE Jr, et al: Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 48: 503–35, 2009.","DOI":"10.1086\/598961"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Cornely OA, Bassetti M, Calandra T, Garbino J, Kullberg BJ, Lortholary O, et al: ESCMID guideline for the diagnosis and management of Candida<\/i> diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect 18 (Suppl 7): 19–37, 2012.","DOI":"10.1111\/1469-0691.12039"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Nielsen SE, Nielsen E, Julian HO, Lindegaard J, H\u00f8jgaard K, Ivarsen A, et al: Incidence and clinical characteristics of fungal keratitis in a Danish population from 2000 to 2013. Acta Ophthalmol 93: 54–8, 2015.","DOI":"10.1111\/aos.12440"},{"key":"5","unstructured":"5) Japanese Society of Ocular Infectious Diseases Committee for the Preparation of the Third Edition of the Clinical Practice Guidelines for Infectious Keratitis: Clinical Practice Guidelines for Infectious Keratitis (3rd Edition). Nippon Ganka Gakkai Zasshi 127: 859–95 2023. [Article in Japanese]"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Ghenciu LA, Faur AC, Bolintineanu SL, Salavat MC, Maghiari AL: Recent advances in diagnosis and treatment approaches in fungal keratitis: a narrative review. Microorganisms 12: 161, 2024.","DOI":"10.3390\/microorganisms12010161"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Raj N, Vanathi M, Ahmed NH, Gupta N, Lomi N, Tandon R: Recent perspectives in the management of fungal keratitis. J Fungi (Basel) 7: 907, 2021.","DOI":"10.3390\/jof7110907"},{"key":"8","unstructured":"8) Inoue Y, Ohashi Y, Suzuki T, Shimomura Y, Fukuda M, Sotozono C, et al: Multicenter prospective observational study of fungal keratitis: current status of patients\u2019 background, clinical findings, treatment and prognosis. Nippon Ganka Gakkai Zasshi 120: 5–16, 2016. [Article in Japanese]"},{"key":"9","unstructured":"9) Sunada A, Asari S, Inoue Y, Ohashi Y, Suzuki T, Shimomura Y, et al: Multicenter prospective observational study of fungal keratitis: identification and susceptibility test of fungi. Nippon Ganka Gakkai Zasshi 120: 17–27, 2016. [Article in Japanese]"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Kawakami H, Inuzuka H, Hori N, Takahashi N, Ishida K, Mochizuki K, et al: Inhibitory effects of antimicrobial agents against Fusarium<\/i> species. Med Mycol 53: 603–11, 2015.","DOI":"10.1093\/mmy\/myv016"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Sharma S, Das S, Joseph J, Vemuganti GK, Murthy S: Microsporidial keratitis: need for increased awareness. Surv Ophthalmol 56: 1–22, 2011.","DOI":"10.1016\/j.survophthal.2010.03.006"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Tuft S, Stone NRH, Burton MJ, Johnson EM, Borman AM: Antifungal susceptibility profiles for fungal isolates from corneas and contact lenses in the United Kingdom. Eye 38: 529–36, 2024.","DOI":"10.1038\/s41433-023-02719-1"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Tu EY, McCartney DL, Beatty RF, Springer KL, Levy J, Edward D: Successful treatment of resistant ocular fusariosis with posaconazole. Am J Ophthalmol 143: 222–7, 2007.","DOI":"10.1016\/j.ajo.2006.10.048"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Arnoldner MA, Kheirkhah A, Jakobiec FA, Durand ML, Hamrah P: Successful treatment of Paecilomyces lilacinus<\/i> keratitis with oral posaconazole. Cornea 33: 747–9, 2014.","DOI":"10.1097\/ICO.0000000000000143"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Fisher JF, Taylor AT, Clark J, Rao R, Espinel-Ingroff A: Penetration of amphotericin B into the human eye. J Infect Dis 147: 164, 1983.","DOI":"10.1093\/infdis\/147.1.164"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Ando T, Kawakami H, Mochizuki K, Murata K, Manabe Y, Takagi D, et al: Intraocular penetration of liposomal amphotericin B after intravenous injection in inflamed human eyes. J Infect Chemother 27: 1319–22, 2021.","DOI":"10.1016\/j.jiac.2021.04.020"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) O\u2019Day DM, Head WS, Robinson RD, Stern WH, Freeman JM: Intraocular penetration of systemically administered antifungal agents. Curr Eye Res 4: 131–4, 1985.","DOI":"10.3109\/02713688508999978"},{"key":"18","unstructured":"18) Yamashita Y, Mochizuki K, Torisaki M, Higashide T, Tanabe J, Komatsu M, et al: Intraocular penetration of systemic fluconazole in a case of endogenous fungal endophthalmitis. Rinsho Ganka 47: 647–51, 1993. [Article in Japanese]"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Hariprasad SM, Mieler WF, Holz ER, Gao H, Kim JE, Chi J, et al: Vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans. Arch Ophthalmol 122: 42–7, 2004.","DOI":"10.1001\/archopht.122.1.42"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Mochizuki K, Niwa Y, Ishida K, Kawakami H: Intraocular penetration of itraconazole in patient with fungal endophthalmitis. Int Ophthalmol 33: 579–81, 2013.","DOI":"10.1007\/s10792-012-9696-0"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Sponsel WE, Graybill JR, Nevarez HL, Dang D: Ocular and systemic posaconazole (SCH-56592) treatment of invasive Fusarium solani<\/i> keratitis and endophthalmitis. Br J Ophthalmol 86: 829–30, 2002.","DOI":"10.1136\/bjo.86.7.829-a"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Mochizuki K, Sawada A, Suemori S, Kawakami H, Niwa Y, Kondo Y, et al: Intraocular penetration of intravenous micafungin in inflamed human eyes. Antimicrob Agents Chemother 57: 4027–30, 2013.","DOI":"10.1128\/AAC.02300-12"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Spriet I, Delaere L, Lagrou K, Peetermans WE, Maertens J, Willems L: Intraocular penetration of voriconazole and caspofungin in a patient with fungal endophthalmitis. J Antimicrob Chemother 64: 877–8, 2009.","DOI":"10.1093\/jac\/dkp306"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Gauthier GM, Nork TM, Prince R, Andes D: Subtherapeutic ocular penetration of caspofungin and associated treatment failure in Candida albicans<\/i> endophthalmitis. Clin Infect Dis 41: e27–8, 2005.","DOI":"10.1086\/431761"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Prajna NV, Krishnan T, Rajaraman R, Patel S, Shah R, Srinivasan M, et al: Adjunctive oral voriconazole treatment of Fusarium<\/i> keratitis: a secondary analysis from the Mycotic Ulcer Treatment Trial II. JAMA Ophthalmol 135: 520–5, 2017.","DOI":"10.1001\/jamaophthalmol.2017.0616"},{"key":"26","unstructured":"26) Kondo K, Inuzuka M, Nakashima A, Sakai S, Mochizuki K, Sawada A: A case of successful systemic antifungal therapy for fungal keratitis caused by Candida albicans<\/i>. Ganka 68: 179–85, 2026."},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Vilela RC, Vilela L, Vilela P, Vilela R, Motta R, P\u00f6ssa AP, et al: Etiological agents of fungal endophthalmitis: diagnosis and management. Int Ophthalmol 34: 707–21, 2014.","DOI":"10.1007\/s10792-013-9854-z"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Gounder PA, Hille DM, Khoo YJ, Phagura RS, Chen FK: Endogenous endophthalmitis in Western Australia: a sixteen-year retrospective study. Retina 40: 908–18, 2020.","DOI":"10.1097\/IAE.0000000000002512"},{"key":"29","unstructured":"29) Ly V, Sallam A: Fungal endophthalmitis. In<\/i> StatPearls. Treasure Island (FL): StatPearls Publishing, 2021."},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Kokuzawa S, Suemori S, Mochizuki K, Hirose Y, Yaguchi T: Aspergillus tubingenesis<\/i> endophthalmitis after cataract surgery with implantation of preloaded intraocular lens. Semin Ophthalmol 29: 218–21, 2014.","DOI":"10.3109\/08820538.2013.835843"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Roy A, Sahu SK, Padhi TR, Das S, Sharma S: Clinicomicrobiological characteristics and treatment outcome of sclerocorneal tunnel infection. Cornea 31: 780–5, 2012.","DOI":"10.1097\/ICO.0b013e3182254b62"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Wykoff CC, Flynn HW Jr, Miller D, Scott IU, Alfonso EC: Exogenous fungal endophthalmitis: microbiology and clinical outcomes. Ophthalmology 115: 1501–7, 2008.","DOI":"10.1016\/j.ophtha.2008.02.027"},{"key":"33","unstructured":"33) Kawakami H, Inuzuka H, Mochizuki K, Takahashi N, Muto T, Ohkusu K, et al: Clinical manifestations, treatment and outcome of ocular infections caused by Paecilomyces<\/i> species. Nippon Ganka Gakkai Zasshi 116: 613–22, 2012. [Article in Japanese]"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Lingappan A, Wykoff CC, Albini TA, Miller D, Pathengay A, Davis JL, et al: Endogenous fungal endophthalmitis: causative organisms, management strategies, and visual acuity outcomes. Am J Ophthalmol 153: 162–6.e1, 2012.","DOI":"10.1016\/j.ajo.2011.06.020"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Behera UC, Budhwani M, Das T, Basu S, Padhi TR, Barik MR, et al: Role of early vitrectomy in the treatment of fungal endophthalmitis. Retina 38: 1385–92, 2018.","DOI":"10.1097\/IAE.0000000000001727"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Sridhar J, Flynn HW Jr, Kuriyan AE, Miller D, Albini T: Endogenous fungal endophthalmitis: risk factors, clinical features, and treatment outcomes in mold and yeast infections. J Ophthalmic Inflamm Infect 3: 60, 2013.","DOI":"10.1186\/1869-5760-3-60"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Weishaar PD, Flynn HW Jr, Murray TG, Davis JL, Barr CC, Gross JG, et al: Endogenous Aspergillus<\/i> endophthalmitis: clinical features and treatment outcomes. Ophthalmology 105: 57–65, 1998.","DOI":"10.1016\/S0161-6420(98)71225-3"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Burton E, Reddy V, Venkat AG: Endogenous fungal endophthalmitis: a single-center retrospective study and review of the literature. Am J Ophthalmol 262: 97–106, 2024.","DOI":"10.1016\/j.ajo.2024.01.018"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Vergoulidou M, Krause L, Foerster MH, Thiel E, Schwartz S: Endogenous filamentous fungal endophthalmitis: Single-centre survey in patients with acute leukaemia or postallogeneic stem cell transplantation and review of the literature. Mycoses 54: e704–11, 2011.","DOI":"10.1111\/j.1439-0507.2010.02004.x"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Kharel Sitaula R, Janani MK, Madhavan HN, Biswas J: Outcome of polymerase chain reaction (PCR) analysis in 100 suspected cases of infectious uveitis. J Ophthalmic Inflamm Infect 8: 2, 2018.","DOI":"10.1186\/s12348-017-0144-1"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Izumikawa K, Kakeya H, Sakai F, Shibuya K, Sugita T, Takazono T, et al: Executive summary of JSMM clinical practice guidelines for diagnosis and treatment of cryptococcosis 2019. Med Mycol J 61: 61–89, 2020.","DOI":"10.3314\/mmj.20.001"},{"key":"42","unstructured":"42) The Japanese Society for Medical Mycology: JSMM Clinical Practice Guidelines for Diagnosis and Treatment of Aspergillosis<\/i>. The Japanese Society for Medical Mycology, Tokyo, 2015. (in Japanese)"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Meletiadis J, Mouton JW, Meis JF, Verweij PE: In vitro<\/i> drug interaction modeling of combinations of azoles with terbinafine against Scedosporium prolificans<\/i> isolates. Antimicrob Agents Chemother 47: 106–17, 2003.","DOI":"10.1128\/AAC.47.1.106-117.2003"},{"key":"44","unstructured":"44) Inoda S, Sato Y, Arai Y, Obata H, Suzuki J, Kaburaki T, et al: Bilateral endogenous fungal subretinal abscesses due to Scedosporium prolificans<\/i>: a case report. Nippon Ganka Gakkai Zasshi 119: 632–9, 2015. [Article in Japanese]"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Oke I, Loporchio DF, Siegel NH, Subramanian ML, LaMattina KC: Chorioretinal paracoccidioidomycosis treated with intravitreal voriconazole and therapeutic vitrectomy. Am J Ophthalmol Case Rep 23: 101187, 2021.","DOI":"10.1016\/j.ajoc.2021.101187"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Sakai D, Imai H, Nakamura M: Multiple intravitreal liposomal amphotericin B for a case of Candida glabrata<\/i> endophthalmitis. Case Rep Ophthalmol 12: 485–91, 2021.","DOI":"10.1159\/000511594"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Peyman GA, Lad EM, Moshfeghi DM: Intravitreal injection of therapeutic agents. Retina 29: 875–912, 2009.","DOI":"10.1097\/IAE.0b013e3181a94f01"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Garrido-Marin M, Kirkegaard Biosca E, Boixadera A, Fischer Fernandez R, S\u00e1nchez Vela L, Pardo Aranda A, et al: Multiresistant Candida<\/i> endophthalmitis treated with intravitreal caspofungin: A case report. Ocul Immunol Inflamm 32: 858–62, 2024.","DOI":"10.1080\/09273948.2023.2168701"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Karachrysafi S, Kourti M, Tsokkou S, Ioannou D, Kofidou E, Delis G, et al: Ultrastructural and immunohistochemical study of double and combined intravitreal administration of antifungal agents in the retina of New Zealand albino rabbits: An experimental protocol. J Fungi (Basel) 11: 564, 2025.","DOI":"10.3390\/jof11080564"},{"key":"50","unstructured":"50) Suzuki T: Retinal toxicity of intravitreal antibiotics. Jpn J Ophthalm Surg 26: 204–8, 2013. [Article in Japanese]"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51) Oude Lashof AM, Rothova A, Sobel JD, Ruhnke M, Pappas PG, Viscoli C, et al: Ocular manifestations of candidemia. Clin Infect Dis 53: 262–8, 2011.","DOI":"10.1093\/cid\/cir355"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52) Ueda T, Takesue Y, Tokimatsu I, Miyazaki T, Nakada-Motokawa N, Nagao M, et al: Incidence of endophthalmitis or macular involvement and necessity of routine ophthalmic examination in candidemia. PLoS One 14: e0216956, 2019.","DOI":"10.1371\/journal.pone.0216956"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53) Breazzano MP, Bond JB 3rd, Bearelly S, Kim DH, Donahue SP, Lum F, et al: American academy of ophthalmology recommendations on screening for endogenous Candida<\/i> endophthalmitis. Ophthalmology 129: 73–6, 2022.","DOI":"10.1016\/j.ophtha.2021.07.015"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54) You EL, H\u00e9bert M, Dufresne SF, Aubin MJ: On the American Academy recommendations for cancelling routine screening for ocular candidiasis: are we being too hasty? Eye (Lond) 38: 2483–4, 2024.","DOI":"10.1038\/s41433-024-02999-1"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55) Lehman A, Tessier KM, Sattarova V, Montezuma SR, Kline S, Erayil SE: Do patients with candidemia need an ophthalmologic examination? Open Forum Infect Dis 11: ofae663, 2024.","DOI":"10.1093\/ofid\/ofae663"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56) Mishra AV, Loh GK, Ehmann DS: Inpatient ophthalmology consultations for candidemia: a literature review and opinion. Curr Opin Ophthalmol 36: 161–6, 2025.","DOI":"10.1097\/ICU.0000000000001128"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57) Miyase T, Mochizuki K, Kawakami H, Yonetamari J, Inuzuka M, Sakai S, et al: Identifying novel risk factors for ocular lesions in patients with fungemia and determining the efficacy of routine screening. Jpn J Ophthalmol 69: 982–90, 2025.","DOI":"10.1007\/s10384-025-01269-1"}],"container-title":["Medical Mycology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/mmj\/67\/2\/67_137\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T03:28:55Z","timestamp":1780716535000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/mmj\/67\/2\/67_137\/_article"}},"subtitle":["Focus on Keratitis and Endophthalmitis Caused by Rare Fungi"],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.3314\/mmj.26.011","relation":{},"ISSN":["2185-6486","2186-165X"],"issn-type":[{"value":"2185-6486","type":"print"},{"value":"2186-165X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]}}}